| Literature DB >> 23440180 |
Whitney A Dillon1, Jeanette C Prorok, Dallas P Seitz.
Abstract
PURPOSE: Information about dementia is important for persons with dementia (PWD) and their caregivers and the Internet has become the key source of health information. We reviewed the content and quality of information provided on Canadian websites for Alzheimer's disease (AD).Entities:
Keywords: Alzheimer’s disease; Internet; dementia; health information
Year: 2013 PMID: 23440180 PMCID: PMC3578772 DOI: 10.5770/cgj.16.40
Source DB: PubMed Journal: Can Geriatr J ISSN: 1925-8348
Guideline recommendations from the Canadian Consensus Conference on Diagnosis and Treatment of Dementia evaluated on Canadian dementia websites
|
Explanation of difference between normal aging, mild cognitive impairment, and dementia( Cognitive symptoms and other features associated with dementia( Explanation of the different types of dementia including Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, and frontotemporal dementia( Role of cognitive screening tests and neuropsychological evaluation in diagnosis of dementia( Role of neuroimaging in the evaluation and diagnosis of dementia( Disclosure of diagnosis to the person with dementia( Evidence for non-pharmacological interventions to treat cognitive symptoms of dementia( Prognosis and natural progression of dementia( Use of cholinesterase inhibitors including risks, benefits associated with treatment( Use of memantine including risks and benefits associated with treatment( Description of behavioral symptoms associated with dementia including depressive symptoms, agitation, psychosis( Community resources that may be helpful to persons with dementia or their caregivers with specific mention Alzheimer Society( Effects of dementia on driving safety( Support networks available to caregivers of individuals with dementia( Identifying caregiver stress and methods to reduce caregiver stress( Information about the genetics of Alzheimer’s disease and familial risk of dementia( |
DISCERN instrument for judging the quality of written consumer health information on treatment choices(
|
Are the aims clear? Does it achieve its aims? Is it relevant? Is it clear what sources of information were used to compile the publication? Is it clear when the information used or reported in the publication was produced? Is it balanced and unbiased? Does it provide details of additional sources of support and information? Does it refer to areas of uncertainty? Does it describe how each treatment works? Does it describe the benefits of each treatment? Does it describe the risks of each treatment? Does it describe what would happen if no treatment is used? Does it describe how the treatment choices affect overall quality of life? Is it clear that there may be more than one possible treatment choice? Does it provide support for shared decision making? Based on the answers to all of the above questions, rate the overall quality of the publication as a source of information about treatment choices. |
Note: Each item is rated from 1 to 5, with 1 = No, 2–4 = Partially achieved, 5 = Yes.
Canadian dementia websites evaluated
| 1. Body + Health | 1 | 7 | |
| 2. Dementia Guide | 2 | -- | |
| 3. Dementia Journey | 5 | -- | |
| 4. Toronto Dementia Network | 8 | -- | |
| 5. Veteran’s Affairs Canada: Dementia and Alzheimer Disease | 12 | 59 | |
| 6. Alzheimer’s Society of Canada | 22 | 1 | |
| 7. Alzheimer’s Foundation Caregiving | -- | 6 |
Website is now found at: www.alzheimerbc.org/Living-With-Dementia/Dementia-Journey.aspx
Website is now found at: www.veterans.gc.ca/eng/health/dementia
Assessment of dementia website content compared to Canadian Consensus Guidelines on the Diagnosis and Treatment of Dementia
| Difference between mild cognitive impairment, normal aging and dementia | Y | Y | Y | N | N | N | Y | 4 (65) |
| Symptoms and associated features of dementia | Y | Y | Y | Y | Y | Y | Y | 7 (100) |
| Different types of dementia | Y | Y | Y | Y | N | Y | Y | 6 (86) |
| Role of cognitive testing in evaluating dementia | N | Y | Y | Y | N | Y | Y | 5 (71) |
| Utility of neuroimaging in diagnosing dementia | Y | Y | Y | Y | N | Y | Y | 6 (86) |
| Disclosure of diagnosis to the patient with dementia | N | Y | Y | N | N | Y | Y | 4 (57) |
| Evidence to support non-pharmacological treatments | N | Y | N | Y | N | Y | Y | 4 (57) |
| Prognosis and natural progression of dementia | Y | Y | Y | N | Y | Y | Y | 6 (86) |
| Cholinesterase inhibitors: benefits, side effects, duration of treatment | N | Y | Y | N | N | Y | Y | 4 (57) |
| Memantine | N | Y | Y | Y | N | Y | Y | 5 (71) |
| Behavioral symptoms associated with dementia | N | Y | Y | Y | N | Y | Y | 5 (71) |
| Community resources with specific mention to Alzheimer Society | N | Y | Y | Y | Y | Y | N | 5 (71) |
| Impact of dementia on driving | N | Y | Y | Y | N | Y | N | 4 (57) |
| Caregiver support networks | N | Y | Y | Y | Y | Y | Y | 6 (86) |
| Assessment and management of caregiver stress | N | Y | Y | Y | N | Y | Y | 5 (71) |
| Genetic risk factors | Y | Y | N | Y | Y | Y | Y | 6 (86) |
| Total Number of Dementia Guideline Topics Addressed, N (%) | 6 (63) | 16 (100) | 14 (88) | 12 (75) | 5 (31) | 15 (96) | 14 (88) |
Quality of information provided on Canadian dementia websites according to the DISCERN instrument
| Explicit Aims | 1 | 4.5 | 5 | 3.5 | 3 | 4 | 5 | 6 (86) |
| Aims Achieved | 1 | 4 | 4.5 | 4 | 2.5 | 5 | 4 | 6 (86) |
| Relevant to consumers | 2.5 | 4 | 5 | 3 | 2.5 | 5 | 4 | 5 (71) |
| Make sources of information explicit | 1 | 3.5 | 4 | 4 | 2.5 | 2.5 | 3 | 4 (57) |
| Make date of information explicit | 1.5 | 4 | 3.5 | 4 | 3.5 | 3 | 3 | 6(86) |
| Be balanced and unbiased | 2.5 | 3 | 4.5 | 5 | 3 | 4.5 | 3.5 | 6 (86) |
| List additional sources of information | 1 | 5 | 5 | 5 | 4 | 4 | 3.5 | 6 (86) |
| Refer to areas of uncertainty | 2 | 3.5 | 4 | 3 | 2.5 | 4 | 3.5 | 5 (71) |
| Describe how treatment works | 1.5 | 4.5 | 5 | 1 | 1 | 5 | 2 | 3 (43) |
| Describe the benefits of treatment | 2 | 4 | 4.5 | 1 | 1 | 4 | 2 | 3 (43) |
| Describe the risks of treatment | 1 | 4 | 4 | 1 | 1 | 4 | 1 | 3 (43) |
| Describe what would happen without treatment | 1 | 2.5 | 1.5 | 1 | 1 | 2 | 2 | 0 (0) |
| Describe the effects of treatment choices on overall quality of life | 1 | 4 | 1.5 | 1 | 1 | 2.5 | 1 | 1 (14) |
| Make it clear there may be more than one possible treatment choice | 2 | 5 | 4.5 | 3 | 1 | 4 | 2.5 | 4 (57) |
| Provide support for shared decision-making | 1.5 | 5 | 5 | 2.5 | 1.5 | 4.5 | 3 | 4 (57) |
| Overall quality of the publication as a source of information about treatment choices | 1 | 4 | 5 | 3 | 1 | 4.5 | 3 | 5 (71) |
| Total Number of DISCERN Domains with Average Score of ≥ 3, N (%) | 0 (0) | 15 (94) | 14 (88) | 10 (63) | 4 (25) | 13 (81) | 10 (63) | -- |
| DISCERN Total Score, Mean (SD) | 23.5 (2.1) | 64.5 (10.6) | 66.5 (0.7) | 44 (11.3) | 32 (9.9) | 62.5 (9.2) | 46 (17.0) | -- |
N = number, SD = standard deviation.